United Asset Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.01M Sell
4,174
-125
-3% -$128K 0.35% 66
2026
Q1
$3.95M Sell
4,299
-234
-5% -$237K 0.31% 69
2025
Q4
$4.87M Sell
4,533
-37
-0.8% -$35.4K 0.38% 62
2025
Q3
$3.49M Buy
4,570
+295
+7% +$220K 0.28% 65
2025
Q2
$3.33M Buy
4,275
+98
+2% +$76.2K 0.28% 70
2025
Q1
$3.45M Sell
4,177
-127
-3% -$106K 0.32% 69
2024
Q4
$3.32M Buy
4,304
+161
+4% +$133K 0.3% 69
2024
Q3
$3.67M Sell
4,143
-1,153
-22% -$1.04M 0.34% 64
2024
Q2
$4.79M Buy
5,296
+214
+4% +$171K 0.47% 57
2024
Q1
$3.95M Buy
5,082
+174
+4% +$124K 0.39% 62
2023
Q4
$2.86M Sell
4,908
-206
-4% -$120K 0.32% 69
2023
Q3
$2.75M Sell
5,114
-500
-9% -$258K 0.36% 66
2023
Q2
$2.63M Buy
5,614
+1,751
+45% +$734K 0.33% 68
2023
Q1
$1.33M Sell
3,863
-149
-4% -$50.3K 0.18% 118
2022
Q4
$1.47M Buy
4,012
+3,333
+491% +$1.18M 0.2% 98
2022
Q3
$220K Sell
679
-3
-0.4% -$951 0.03% 191
2022
Q2
$221K Buy
+682
New +$205K 0.03% 191
2022
Q1
Sell
-750
Closed -$207K 226
2021
Q4
$207K Buy
+750
New +$190K 0.02% 196
2020
Q4
Sell
-3,718
Closed -$550K 212
2020
Q3
$550K Buy
3,718
+364
+11% +$56.3K 0.1% 130
2020
Q2
$551K Buy
+3,354
New +$515K 0.11% 122
2019
Q1
Sell
-4,116
Closed -$476K 207
2018
Q4
$476K Sell
4,116
-9,085
-69% -$1.01M 0.13% 133
2018
Q3
$1.42M Buy
13,201
+793
+6% +$79.3K 0.33% 71
2018
Q2
$1.06M Buy
12,408
+1,737
+16% +$143K 0.28% 90
2018
Q1
$826K Buy
10,671
+767
+8% +$61.7K 0.24% 96
2017
Q4
$836K Buy
9,904
+1,731
+21% +$147K 0.22% 95
2017
Q3
$699K Buy
8,173
+3,122
+62% +$256K 0.4% 58
2017
Q2
$416K Buy
+5,051
New +$412K 0.12% 111

Other funds holding LLY

United Asset Strategies's LLY Position: Q2 2026 in Review

United Asset Strategies reduced its Eli Lilly (LLY) stake by 2.9% in Q2 2026, selling an estimated $128K and leaving 4,174 shares worth $5.01M. The position accounts for 0.35% of the portfolio, ranked #66.

United Asset Strategies first reported a position in LLY in Q2 2017 and has held it in 27 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • United Asset Strategies held 4,174 shares of Eli Lilly worth $5.01M as of Q2 2026.
  • United Asset Strategies sold 125 Eli Lilly shares in Q2 2026, an estimated $128K.
  • Eli Lilly made up 0.35% of United Asset Strategies's portfolio in Q2 2026, its #66 holding.
  • United Asset Strategies first reported a position in Eli Lilly in Q2 2017 and has held it in 27 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on United Asset Strategies's 13F filing for Q2 2026, filed 13 Jul 2026.